Masimo Root News Today

Masimo today announced it received CE mark approval for its LiDCO board-in-cable (BIC) module in hemodynamic monitoring.

Masimo NASDAQ MASI today announced the CE mark under the European Union Medical Device Regulation for the LiDCO boardincable BIC module.

30.11.2022 - Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan. In the study, Dr. Sukriye Akdag and colleagues at Marmara ... Seite 1

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Anesthesia & Analgesia in which Dr. Claudia Spies and colleagues investigated the relationship between parameters derived from electroencephalogram (EEG) spectra, measured using Masimo SedLine® Brain Function Monitoring, and postoperative delirium (POD) in older patients undergoing elective surgery.

May 11, 2021 healthcaretechnology Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr. Debdipta Das and colleagues at Medical College Kolkata in India evaluated the utility of Masimo O3® Regional Oximetry to aid in monitoring septic shock patients admitted to the ICU.1 O3, av...

(Photo by John Fedele/ Getty Images)  The interoperability and connectivity of medical devices are widely recognised as important factors in helping hospitals achieve better patient data flow, synchronisation and harmonisation. “Hospitals need to connect devices that are not natively connected and maximise interoperability across the continuum of care so all patient data can be accurately and efficiently captured and presented to clinicians in the most suitable ways,” explains Joe Kiani, C...

Article content Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARD...

Press release content from Business Wire. The AP news staff was not involved in its creation. Masimo Monitoring Solutions Promote Newborn and Maternal Safety March 8, 2021 GMT Masimo Newborn Sensor (Photo: Masimo) NEUCHATEL, Switzerland--(BUSINESS WIRE)--Mar 8, 2021-- Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to meas...